We are live on ! Find out more
AC

Avestar Capital Portfolio holdings

AUM $1.79B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+33.8%
3 Year Est. Return
+101.14%
5 Year Est. Return
+116.39%
10 Year Est. Return
AUM
$882M
AUM Growth
+$179M
Cap. Flow
+$120M
Cap. Flow %
13.58%
Top 10 Hldgs %
38.72%
Holding
447
New
79
Increased
203
Reduced
92
Closed
57
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
276
Progressive
PGR
$123B
$334K 0.04%
2,099
+421
+25% +$65.9K
KLAC icon
277
KLA
KLAC
$239B
$330K 0.04%
+5,670
New +$295K
PLD icon
278
Prologis
PLD
$135B
$328K 0.04%
2,463
+606
+33% +$68.8K
AZN icon
279
AstraZeneca
AZN
$263B
$327K 0.04%
2,431
+18
+0.7% +$2.34K
VNT icon
280
Vontier
VNT
$4.52B
$325K 0.04%
9,414
-111
-1% -$3.61K
FLR icon
281
Fluor
FLR
$7.01B
$324K 0.04%
8,261
-694
-8% -$25.6K
REGN icon
282
Regeneron Pharmaceuticals
REGN
$78.5B
$321K 0.04%
+365
New +$301K
HUBB icon
283
Hubbell
HUBB
$25B
$319K 0.04%
971
+45
+5% +$13.5K
F icon
284
Ford
F
$58.5B
$319K 0.04%
26,174
-11,151
-30% -$124K
RWK icon
285
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.31B
$318K 0.04%
+3,023
New +$288K
CRL icon
286
Charles River Laboratories
CRL
$11.2B
$315K 0.04%
1,331
-119
-8% -$23.4K
NVO
287
CALL
Novo Nordisk
NVO
$208B
$310K 0.04%
+3,000
New +$297K
VTWO icon
288
Vanguard Russell 2000 ETF
VTWO
$17.3B
$306K 0.03%
3,773
CB icon
289
Chubb
CB
$135B
$306K 0.03%
1,349
+259
+24% +$56.6K
SO icon
290
Southern Company
SO
$109B
$306K 0.03%
4,361
+900
+26% +$61.8K
BMY icon
291
Bristol-Myers Squibb
BMY
$133B
$303K 0.03%
5,903
+197
+3% +$10.3K
DXCM icon
292
DexCom
DXCM
$31.5B
$303K 0.03%
+2,440
New +$249K
ZS icon
293
Zscaler
ZS
$24.5B
$302K 0.03%
1,361
+584
+75% +$108K
PCAR icon
294
PACCAR
PCAR
$69.8B
$302K 0.03%
+3,009
New +$270K
BWXT icon
295
BWX Technologies
BWXT
$15.5B
$297K 0.03%
3,877
-175
-4% -$13.5K
HSY icon
296
Hershey
HSY
$35.2B
$297K 0.03%
1,592
+19
+1% +$3.6K
FAF icon
297
First American
FAF
$7.66B
$297K 0.03%
4,603
-287
-6% -$16.4K
PYPL icon
298
PayPal
PYPL
$48.9B
$295K 0.03%
4,800
-432
-8% -$24.7K
MNST icon
299
Monster Beverage
MNST
$94.3B
$294K 0.03%
5,103
+508
+11% +$27.1K
DOW icon
300
Dow Inc
DOW
$21.9B
$294K 0.03%
5,357
+784
+17% +$40.1K

Similar funds

Avestar Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Avestar Capital held 447 positions worth $882M, up 25% from $703M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Avestar Capital deployed $120M of net new capital in Q4 2023, opening 79 new positions and adding to 203 existing holdings. Its largest new stake was State Street SPDR S&P Emerging Markets Dividend ETF: 152,400 shares worth $4.96M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Invesco S&P 500 Equal Weight ETF, an estimated $4.84M trimmed.

  • Avestar Capital's largest Q4 2023 buy was State Street SPDR S&P Emerging Markets Dividend ETF: 152,400 shares worth $4.96M.
  • Avestar Capital added most to State Street Ultra Short Term Bond ETF in Q4 2023, an estimated $19.5M increase.
  • Avestar Capital's biggest Q4 2023 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $4.84M.
  • Avestar Capital fully exited Dimensional Emerging Markets Core Equity 2 ETF in Q4 2023, selling an estimated $5.55M.
  • Avestar Capital's ten largest holdings make up 39% of its $882M portfolio in Q4 2023.
  • Avestar Capital opened 79 new positions and closed 57 in Q4 2023.
  • Avestar Capital's portfolio value rose 25% quarter-over-quarter to $882M.

Based on Avestar Capital's 13F filing for Q4 2023, filed 12 Feb 2024.